These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Impaired glucose sensitivity of ATP-sensitive K+ channels in pancreatic beta-cells in streptozotocin-induced NIDDM rats. Tsuura Y; Ishida H; Okamoto Y; Tsuji K; Kurose T; Horie M; Imura H; Okada Y; Seino Y Diabetes; 1992 Jul; 41(7):861-5. PubMed ID: 1612201 [TBL] [Abstract][Full Text] [Related]
29. What kind of cardiovascular alterations could be influenced positively by oral antidiabetic agents? Pogátsa G Diabetes Res Clin Pract; 1996 Jul; 31 Suppl():S27-31. PubMed ID: 8864638 [TBL] [Abstract][Full Text] [Related]
30. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries. Nielsen-Kudsk JE Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816 [TBL] [Abstract][Full Text] [Related]
31. ATP gated potassium channels in acute myocardial hibernation and reperfusion. Offstad J; Kirkebøen KA; Ilebekk A; Downing SE Cardiovasc Res; 1994 Jun; 28(6):872-80. PubMed ID: 7923294 [TBL] [Abstract][Full Text] [Related]
32. Blockade of adenosine triphosphate-sensitive potassium channels by thiamylal in rat ventricular myocytes. Tsutsumi Y; Oshita S; Kitahata H; Kuroda Y; Kawano T; Nakaya Y Anesthesiology; 2000 Apr; 92(4):1154-9. PubMed ID: 10754636 [TBL] [Abstract][Full Text] [Related]
33. The high-affinity sulphonylurea receptor regulates KATP channels in nerve terminals of the rat motor cortex. Lee K; Dixon AK; Rowe IC; Ashford ML; Richardson PJ J Neurochem; 1996 Jun; 66(6):2562-71. PubMed ID: 8632183 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of ATP-sensitive K+ channels in cardiac muscle by the sulphonylurea drug glibenclamide. Findlay I J Pharmacol Exp Ther; 1992 May; 261(2):540-5. PubMed ID: 1578371 [TBL] [Abstract][Full Text] [Related]
35. Gliclazide produces high-affinity block of KATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells. Lawrence CL; Proks P; Rodrigo GC; Jones P; Hayabuchi Y; Standen NB; Ashcroft FM Diabetologia; 2001 Aug; 44(8):1019-25. PubMed ID: 11484080 [TBL] [Abstract][Full Text] [Related]
36. Sulphonylurea drugs no longer inhibit ATP-sensitive K+ channels during metabolic stress in cardiac muscle. Findlay I J Pharmacol Exp Ther; 1993 Jul; 266(1):456-67. PubMed ID: 8331572 [TBL] [Abstract][Full Text] [Related]
37. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Quayle JM; Nelson MT; Standen NB Physiol Rev; 1997 Oct; 77(4):1165-232. PubMed ID: 9354814 [TBL] [Abstract][Full Text] [Related]
38. Cardiac ATP-sensitive K+ channels: regulation by intracellular nucleotides and K+ channel-opening drugs. Terzic A; Jahangir A; Kurachi Y Am J Physiol; 1995 Sep; 269(3 Pt 1):C525-45. PubMed ID: 7573382 [TBL] [Abstract][Full Text] [Related]
39. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury. Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485 [TBL] [Abstract][Full Text] [Related]